NDC 0363-2529

Bronchial Asthma Relief

Ephedrine Hcl, Guaifenesin

Bronchial Asthma Relief is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Walgreens Company. The primary component is Guaifenesin; Ephedrine Hydrochloride.

Product ID0363-2529_74ac83c5-db2e-485f-8fe4-0c29f94e1006
NDC0363-2529
Product TypeHuman Otc Drug
Proprietary NameBronchial Asthma Relief
Generic NameEphedrine Hcl, Guaifenesin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2002-02-13
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart341
Labeler NameWalgreens Company
Substance NameGUAIFENESIN; EPHEDRINE HYDROCHLORIDE
Active Ingredient Strength200 mg/1; mg/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 0363-2529-67

4 BLISTER PACK in 1 CARTON (0363-2529-67) > 15 TABLET in 1 BLISTER PACK
Marketing Start Date2002-02-13
Marketing End Date2023-04-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0363-2529-67 [00363252967]

Bronchial Asthma Relief TABLET
Marketing CategoryOTC monograph final
Application Numberpart341
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2002-02-13
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
GUAIFENESIN200 mg/1

OpenFDA Data

SPL SET ID:10816e9d-0c53-424b-b482-fdd01a4d8525
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1115991
  • NDC Crossover Matching brand name "Bronchial Asthma Relief" or generic name "Ephedrine Hcl, Guaifenesin"

    NDCBrand NameGeneric Name
    0363-2529Bronchial Asthma ReliefEphedrine HCl, Guaifenesin
    0363-7430Bronchial Asthma ReliefEphedrine HCl, Guaifenesin
    0573-2952PRIMATENEephedrine HCl, guaifenesin

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.